Optical Spectroscopy to Guide Photodynamic Therapy of Head and Neck Tumors
暂无分享,去创建一个
Stephen Chad Kanick | Henricus J C M Sterenborg | Arjen Amelink | Max J H Witjes | Bastiaan Kruijt | Robert L P van Veen | I Bing Tan | M. B. Karakullukcu | I. Tan | M. Witjes | A. Amelink | S. Kanick | D. Robinson | R. V. van Veen | D J Robinson | M Baris Karakullukçu | Robert P L van Veen | H. Sterenborg | B. Kruijt
[1] Thomas H. Foster,et al. In Vivo mTHPC Photobleaching in Normal Rat Skin Exhibits Unique Irradiance-dependent Features¶ , 2002, Photochemistry and photobiology.
[2] L. Kunz,et al. Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver , 2004, British Journal of Cancer.
[3] T. Hasan,et al. PHOTOPHYSICAL AND PHOTOSENSITIZING PROPERTIES OF BENZOPORPHYRIN DERIVATIVE MONOACID RING A (BPD‐MA) * , 1994, Photochemistry and photobiology.
[4] E. Hull,et al. Porphyrin Bleaching and PDT-induced Spectral Changes are Irradiance Dependent in ALA-sensitized Normal Rat Skin In Vivo¶ , 2001, Photochemistry and photobiology.
[5] Jarod C Finlay,et al. Interstitial Fluorescence Spectroscopy in the Human Prostate During Motexafin Lutetium–Mediated Photodynamic Therapy , 2006, Photochemistry and photobiology.
[6] W. Jerjes,et al. The application of photodynamic therapy in the head and neck. , 2007, Dental update.
[7] Ken Kang-Hsin Wang,et al. A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy. , 2006, Medical physics.
[8] B. Krammer,et al. Vascular effects of photodynamic therapy. , 2001, Anticancer research.
[9] Jarod C Finlay,et al. Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy. , 2005, Photochemistry and photobiology.
[10] L. Lilge,et al. Implicit and explicit dosimetry in photodynamic therapy: a New paradigm , 1997, Lasers in Medical Science.
[11] Stefan Andersson-Engels,et al. Towards accurate in vivo spectroscopy of the human prostate , 2008, Journal of biophotonics.
[12] K. Lorenz,et al. Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan®) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients , 2009, European Archives of Oto-Rhino-Laryngology.
[13] Henricus J C M Sterenborg,et al. The importance of in situ dosimetry during photodynamic therapy of Barrett's esophagus. , 2006, Gastrointestinal endoscopy.
[14] Stanley B. Brown,et al. The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.
[15] C. Hadjur,et al. Pharmacokinetics of Tetra (m‐hydroxyphenyl)chlorin in Human Plasma and Individualized Light Dosimetry in Photodynamic Therapy , 1998, Photochemistry and photobiology.
[16] Lise Lyngsnes Randeberg,et al. Monitoring of hexyl 5-aminolevulinate-induced photodynamic therapy in rat bladder cancer by optical spectroscopy. , 2008, Journal of biomedical optics.
[17] B. Kruijt,et al. Laser speckle imaging of dynamic changes in flow during photodynamic therapy , 2006, Lasers in Medical Science.
[18] C. Hadjur,et al. Spectroscopic studies of photobleaching and photoproduct formation of meta(tetrahydroxyphenyl)chlorin (m-THPC) used in photodynamic therapy. The production of singlet oxygen by m-THPC , 1998 .
[19] Timothy C. Zhu,et al. Optical Properties of Human Prostate at 732 nm Measured In Vivo During Motexafin Lutetium–mediated Photodynamic Therapy¶ , 2005 .
[20] Theresa M Busch,et al. Fluence rate as a modulator of PDT mechanisms , 2006, Lasers in surgery and medicine.
[21] Brian W. Pogue,et al. Estimation of Oxygen Distribution in RIF-1 Tumors by Diffusion Model-Based Interpretation of Pimonidazole Hypoxia and Eppendorf Measurements , 2001, Radiation research.
[22] Victor X D Yang,et al. A multispectral fluorescence imaging system: Design and initial clinical tests in intra‐operative Photofrin‐photodynamic therapy of brain tumors , 2003, Lasers in surgery and medicine.
[23] Zheng Huang,et al. Combination of Photodynamic Therapy and Immunomodulation: Current Status and Future Trends , 2008 .
[24] Adrian Mariampillai,et al. Intravital high-resolution optical imaging of individual vessel response to photodynamic treatment. , 2008, Journal of biomedical optics.
[25] T. Mang,et al. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. , 1985, Cancer research.
[26] Arjen Amelink,et al. Measurement of the local optical properties of turbid media by differential path-length spectroscopy. , 2004, Applied optics.
[27] Quantitative fluorescence spectroscopy in turbid media using fluorescence differential path length spectroscopy. , 2008, Journal of biomedical optics.
[28] Thomas Pongratz,et al. ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. , 2007, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[29] Jarod C Finlay,et al. Real-time In Situ Monitoring of Human Prostate Photodynamic Therapy with Diffuse Light , 2006, Photochemistry and photobiology.
[30] W. Star,et al. Light dosimetry in vivo. , 1997, Physics in medicine and biology.
[31] G. Puppels,et al. Towards oncological application of Raman spectroscopy , 2009, Journal of biophotonics.
[32] Michael S Patterson,et al. Relationship Between mTHPC Fluorescence Photobleaching and Cell Viability During In Vitro Photodynamic Treatment of DP16 Cells¶ , 2002, Photochemistry and photobiology.
[33] A. Amelink,et al. Monitoring PDT by means of superficial reflectance spectroscopy. , 2005, Journal of photochemistry and photobiology. B, Biology.
[34] J Moan,et al. PHOTOBLEACHING OF PORPHYRINS USED IN PHOTODYNAMIC THERAPY AND IMPLICATIONS FOR THERAPY , 1987, Photochemistry and photobiology.
[35] P. Lambin,et al. Oxygenation of head and neck tumors , 1993, Cancer.
[36] B. Wilson,et al. Spectroscopy and fluorescence in esophageal diseases. , 2006, Best practice & research. Clinical gastroenterology.
[37] L. Kunz,et al. Intracellular Photobleaching of 5,10,15,20-Tetrakis(m-hydroxyphenyl) chlorin (Foscan®) Exhibits a Complex Dependence on Oxygen Level and Fluence Rate¶ , 2002, Photochemistry and photobiology.
[38] A. Curnow,et al. Optimisation of Illumination for Photodynamic Therapy With mTHPC on Normal Colon and a Transplantable Tumour in Rats , 2002, Lasers in Medical Science.
[39] B. Wilson,et al. The physics, biophysics and technology of photodynamic therapy , 2008, Physics in medicine and biology.
[40] Stanley B. Brown,et al. Fluorescence Photobleaching of ALA‐induced Protoporphyrin IX during Photodynamic Therapy of Normal Hairless Mouse Skin: The Effect of Light Dose and Irradiance and the Resulting Biological Effect , 1998, Photochemistry and photobiology.
[41] Shoko Nioka,et al. Noninvasive diffuse optical measurement of blood flow and blood oxygenation for monitoring radiation therapy in patients with head and neck tumors: a pilot study. , 2006, Journal of biomedical optics.
[42] Arjen Amelink,et al. Monitoring ALA‐induced PpIX Photodynamic Therapy in the Rat Esophagus Using Fluorescence and Reflectance Spectroscopy , 2008, Photochemistry and photobiology.
[43] M. Korbelik,et al. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. , 1999, Cancer research.
[44] Brian W Pogue,et al. Analysis of sampling volume and tissue heterogeneity on the in vivo detection of fluorescence. , 2005, Journal of biomedical optics.
[45] Thomas H Foster,et al. Irradiance-Dependent Photobleaching and Pain in δ-Aminolevulinic Acid-Photodynamic Therapy of Superficial Basal Cell Carcinomas , 2008, Clinical Cancer Research.
[46] Kai Zhang,et al. Techniques for delivery and monitoring of TOOKAD(WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities , 2005, SPIE BiOS.
[47] T. Foster,et al. Effects of Fluence Rate on Cell Survival and Photobleaching in Meta-Tetra-(hydroxyphenyl)chlorin–photosensitized Colo 26 Multicell Tumor Spheroids¶ , 2001, Photochemistry and photobiology.
[48] B. Henderson,et al. BIODISTRIBUTION AND PDT EFFICACY OF A KETOCHLORIN PHOTOSENSITIZER AS A FUNCTION OF THE DELIVERY VEHICLE , 1994, Photochemistry and photobiology.
[49] Wiley Interscience,et al. Performance of a dedicated light delivery and dosimetry device for photodynamic therapy of nasopharyngeal carcinoma: Phantom and volunteer experiments , 2007, Lasers in surgery and medicine.
[50] Michael J. Emanuele,et al. Treatment-Induced Changes in Tumor Oxygenation Predict Photodynamic Therapy Outcome , 2004, Cancer Research.
[51] I J Bigio,et al. Non-invasive measurement of chemotherapy drug concentrations in tissue: preliminary demonstrations of in vivo measurements. , 1999, Physics in medicine and biology.
[52] I. Tan,et al. mTHPC‐mediated photodynamic therapy for early oral squamous cell carcinoma , 2004, International journal of cancer.